ReviewJournal of diabetes science and technology2025

The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists.

Sujatha Seetharaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.